Article metrics

Download PDFPDF

1389 GIGA-564 a third generation anti CTLA 4 with minimal ability to block CTLA 4 binding to B7 ligands has enhanced efficacy but reduced toxicity compared to ipilimumab in preclinical models
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2024

AbstractFullPdf
Nov 2022338029
Dec 202262023
Jan 202328012
Feb 202350019
Mar 202364017
Apr 20234806
May 20233404
Jun 20231602
Jul 202328010
Aug 202354015
Sep 20237409
Oct 20236809
Nov 20238209
Dec 202372014
Jan 20242000
Total10380178